Comparative-Effectiveness

Biopharma Products Not ‘On Radar’ For Medicare Coverage Review

Are You Familiar With PCORI’s Principles Of Collaboration?

PCORI – What’s Next For Hepatitis C Research?

Early Access & Adaptive Licensing – Hot Topics At ISPOR Europe Annual Meeting

Why Is Observational CER Gaining Popularity In China?

Check Out The Newest THETA Rounds Lecture For A Brief History Of The Health Utilities Index

What Is Your Opinion On Informed Consent Rules In Comparison Studies – We Want To Know!

New Draft Guidelines Involving Risks In Comparative-Effectiveness Research – A Confusing Clarification

New Journal Targets Real-World Data, Health Outcomes, Healthcare Decision-Making & Big Data

How Do You Decide The Relevance And Credibility Of Observational Studies?

How Does Crossover Affect Overall Survival Analysis In Randomized Controlled Trials

Videos Promote Ethical Comparative-Effectiveness Research

AMCP’s Pre-Conference Comparative Effectiveness Research Certificate Program

The Politics Of Pharma Pricing: Are We Asking The Right Questions?

Are U.S. Cancer Patients Receiving Better Care Than Europeans?

Does PCORI Have The Capacity To Promote Significant Change?

Symposium On Innovation & Cost-Effectiveness Analysis

EBM – Time To Refresh And Redefine?

Will CER Really Deliver Better Patient Outcomes?

Barriers And Opportunities Of Big Data

CER – What Happens When The Patient Is Not Your “Average” Patient?

How Can We Use RCT Data To Assess Heterogeneity Of Treatment Effecs? Let Me Count The Ways

Scenario-Building Methods And US Scenarios

PCORnet – Enabling Comparative Effectiveness Research In The US

What Can Winnie The Pooh Teach Us About Pharmaceutical Reimbursement?

Evidence Based Medicine: A Movement In Crisis?

Is U.S. Medicare Program’s Use Of CER Consistent With The ACA’s Restrictions?

A Discussion Of Approaches To Knowledge Synthesis

Is Patient-Centricity A Farce?

How Will PCORI’s National Database Revolutionize Research?

Categories

Stay Connected